Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci.
Cervera C, Castañeda X, Pericas JM, Del Río A, de la Maria CG, Mestres C, Falces C, Marco F, Moreno A, Miró JM. Cervera C, et al. Among authors: castaneda x. Int J Antimicrob Agents. 2011 Nov;38(5):365-70. doi: 10.1016/j.ijantimicag.2010.11.038. Epub 2011 Mar 21. Int J Antimicrob Agents. 2011. PMID: 21420835 Review.
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
Miró JM, Entenza JM, Del Río A, Velasco M, Castañeda X, Garcia de la Mària C, Giddey M, Armero Y, Pericàs JM, Cervera C, Mestres CA, Almela M, Falces C, Marco F, Moreillon P, Moreno A; Hospital Clinic Experimental Endocarditis Study Group. Miró JM, et al. Among authors: castaneda x. Antimicrob Agents Chemother. 2012 Aug;56(8):4511-5. doi: 10.1128/AAC.06449-11. Epub 2012 May 29. Antimicrob Agents Chemother. 2012. PMID: 22644033 Free PMC article.
Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
García-de-la-Mària C, Pericas JM, Del Río A, Castañeda X, Vila-Farrés X, Armero Y, Espinal PA, Cervera C, Soy D, Falces C, Ninot S, Almela M, Mestres CA, Gatell JM, Vila J, Moreno A, Marco F, Miró JM; Hospital Clinic Experimental Endocarditis Study Group. García-de-la-Mària C, et al. Among authors: castaneda x. Antimicrob Agents Chemother. 2013 May;57(5):2319-25. doi: 10.1128/AAC.01921-12. Epub 2013 Mar 11. Antimicrob Agents Chemother. 2013. PMID: 23478959 Free PMC article.
Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
Cervera C, Castañeda X, de la Maria CG, del Rio A, Moreno A, Soy D, Pericas JM, Falces C, Armero Y, Almela M, Ninot S, Pare JC, Mestres CA, Gatell JM, Marco F, Miro JM; Hospital Clinic Endocarditis Study Group. Cervera C, et al. Among authors: castaneda x. Clin Infect Dis. 2014 Jun;58(12):1668-75. doi: 10.1093/cid/ciu183. Epub 2014 Mar 18. Clin Infect Dis. 2014. PMID: 24647021
Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration.
García de la Mària C, Cervera C, Pericàs JM, Castañeda X, Armero Y, Soy D, Almela M, Ninot S, Falces C, Mestres CA, Gatell JM, Moreno A, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group. García de la Mària C, et al. Among authors: castaneda x. PLoS One. 2015 May 11;10(5):e0125818. doi: 10.1371/journal.pone.0125818. eCollection 2015. PLoS One. 2015. PMID: 25961578 Free PMC article.
AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis.
Castañeda X, García-de-la-Mària C, Gasch O, Pericas JM, Armero Y, Soy D, García-González J, Falces C, Ninot S, Almela M, Ambrosioni J, Quintana E, Vidal B, Fuster D, Llopis J, Soto S, Moreno A, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group. Castañeda X, et al. Antimicrob Agents Chemother. 2017 May 24;61(6):e02486-16. doi: 10.1128/AAC.02486-16. Print 2017 Jun. Antimicrob Agents Chemother. 2017. PMID: 28373187 Free PMC article.
Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis.
García-de-la-Mària C, Gasch O, Castañeda X, García-González J, Soy D, Cañas MA, Ambrosioni J, Almela M, Pericàs JM, Téllez A, Falces C, Hernández-Meneses M, Sandoval E, Quintana E, Vidal B, Tolosana JM, Fuster D, Llopis J, Moreno A, Marco F, Miró JM; Hospital Clínic Endocarditis Study Group. García-de-la-Mària C, et al. Among authors: castaneda x. J Antimicrob Chemother. 2020 Dec 1;75(12):3586-3592. doi: 10.1093/jac/dkaa354. J Antimicrob Chemother. 2020. PMID: 32853336 Free article.
Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.
Castañeda X, García-De-la-Mària C, Gasch O, Pericàs JM, Soy D, Cañas-Pacheco MA, Falces C, García-González J, Hernández-Meneses M, Vidal B, Almela M, Quintana E, Tolosana JM, Fuster D, Llopis J, Dahl A, Moreno A, Marco F, Miró JM; Hospital Clínic Endocarditis Study Group. Castañeda X, et al. J Antimicrob Chemother. 2021 May 12;76(6):1539-1546. doi: 10.1093/jac/dkab069. J Antimicrob Chemother. 2021. PMID: 33837406 Free article.
Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Miró JM, García-de-la-Mària C, Armero Y, Soy D, Moreno A, del Río A, Almela M, Sarasa M, Mestres CA, Gatell JM, Jiménez de Anta MT, Marco F; Hospital Clinic Experimental Endocarditis Study Group. Miró JM, et al. Antimicrob Agents Chemother. 2009 Oct;53(10):4172-7. doi: 10.1128/AAC.00051-09. Epub 2009 Jul 20. Antimicrob Agents Chemother. 2009. PMID: 19620326 Free PMC article.
Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.
García-de-la-Mària C, Marco F, Armero Y, Soy D, Moreno A, del Río A, Almela M, Cervera C, Ninot S, Falces C, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM; Hospital Clínic Experimental Endocarditis Study Group. García-de-la-Mària C, et al. Antimicrob Agents Chemother. 2010 Jul;54(7):2781-6. doi: 10.1128/AAC.01011-09. Epub 2010 Apr 26. Antimicrob Agents Chemother. 2010. PMID: 20421394 Free PMC article.
50 results